The external validity of MRI-defined vascular depression

Objective Multiple diagnostic criteria have been used to define vascular depression (VD). As a result, there are discrepancies in the clinical characteristics that have been established for the illness. The aim of this study was twofold. First, we used empirically established diagnostic criteria to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of geriatric psychiatry 2013-11, Vol.28 (11), p.1189-1196
Hauptverfasser: Pimontel, Monique A., Reinlieb, Michelle E., Johnert, Lauren C., Garcon, Ernst, Sneed, Joel R., Roose, Steven P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1196
container_issue 11
container_start_page 1189
container_title International journal of geriatric psychiatry
container_volume 28
creator Pimontel, Monique A.
Reinlieb, Michelle E.
Johnert, Lauren C.
Garcon, Ernst
Sneed, Joel R.
Roose, Steven P.
description Objective Multiple diagnostic criteria have been used to define vascular depression (VD). As a result, there are discrepancies in the clinical characteristics that have been established for the illness. The aim of this study was twofold. First, we used empirically established diagnostic criteria to determine the clinical characteristics of magnetic resonance imaging (MRI)‐defined VD. Second, we assessed the agreement between a quantitative and qualitative method for identifying the illness. Method We examined the baseline clinical and neuropsychological profile of 38 patients from a larger, double‐blind, randomized, 12‐week clinical trial comparing nortriptyline with sertraline in depressed older adults. Ten patients met quantitative criteria for MRI‐defined VD based on the highest quartile of deep white matter hyperintensity (DWMH) volume. Fourteen patients met qualitative criteria for MRI‐defined VD based on a DWMH score of 2 or higher on the Fazekas' modified Coffey rating scale. Results Age, gender, cumulative illness rating scale‐geriatric (CIRS‐G) score, two measures of psychomotor retardation [the psychomotor retardation item of the Hamilton Rating Scale for Depression (HRSD) as well as performance on the Purdue Pegboard], and performance on the Stroop Color/Word test (a measure of the response inhibition component of executive functioning) were significantly different between those with VD and non‐VD. Conclusions Patients with VD have a distinct clinical and neuropsychological profile that is mostly consistent across different methods for identifying the illness. These findings support the notion that MRI‐defined VD represents a unique and valid subtype of late‐life depression. Copyright © 2013 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/gps.3943
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1443388705</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3096114741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4173-25366c76f6c2a35e2bac3b79c96bcaae3ccce5f926c967ae3c834e6f615b3e033</originalsourceid><addsrcrecordid>eNp10F1LHDEUBuBQKnW1BX9BGSiCN6NJTiaZuSx-rJZVi27xMmQyZ9rY2Zk12VH335upo0LBq5CTh_eQl5AdRvcZpfzg9zLsQyHgA5kwWhQpY1J-JBOa51kqOdBNshXCLaXxjeWfyCYHIZQAPiH5_A8m-LhC35omuTeNq9xqnXR1cn51llZYuxarOA-2b4xPKlx6DMF17WeyUZsm4Jfx3Ca_To7nh6fp7HJ6dvh9llrBFKQ8AymtkrW03ECGvDQWSlXYQpbWGARrLWZ1wWWcqOGeg8DIWVYCUoBtsvecu_TdXY9hpRcuWGwa02LXB82EAMhzRbNIv_1Hb7t--Nc_xYAxyvlboPVdCB5rvfRuYfxaM6qHNnVsUw9tRvp1DOzLBVav8KW-CHZHEAsyTe1Na114c0opoWAISp_dg2tw_e5CPf15PS4evQsrfHz1xv_VUoHK9M3FVM_E-Q86PZrrU3gCosqYYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1441311022</pqid></control><display><type>article</type><title>The external validity of MRI-defined vascular depression</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Pimontel, Monique A. ; Reinlieb, Michelle E. ; Johnert, Lauren C. ; Garcon, Ernst ; Sneed, Joel R. ; Roose, Steven P.</creator><creatorcontrib>Pimontel, Monique A. ; Reinlieb, Michelle E. ; Johnert, Lauren C. ; Garcon, Ernst ; Sneed, Joel R. ; Roose, Steven P.</creatorcontrib><description>Objective Multiple diagnostic criteria have been used to define vascular depression (VD). As a result, there are discrepancies in the clinical characteristics that have been established for the illness. The aim of this study was twofold. First, we used empirically established diagnostic criteria to determine the clinical characteristics of magnetic resonance imaging (MRI)‐defined VD. Second, we assessed the agreement between a quantitative and qualitative method for identifying the illness. Method We examined the baseline clinical and neuropsychological profile of 38 patients from a larger, double‐blind, randomized, 12‐week clinical trial comparing nortriptyline with sertraline in depressed older adults. Ten patients met quantitative criteria for MRI‐defined VD based on the highest quartile of deep white matter hyperintensity (DWMH) volume. Fourteen patients met qualitative criteria for MRI‐defined VD based on a DWMH score of 2 or higher on the Fazekas' modified Coffey rating scale. Results Age, gender, cumulative illness rating scale‐geriatric (CIRS‐G) score, two measures of psychomotor retardation [the psychomotor retardation item of the Hamilton Rating Scale for Depression (HRSD) as well as performance on the Purdue Pegboard], and performance on the Stroop Color/Word test (a measure of the response inhibition component of executive functioning) were significantly different between those with VD and non‐VD. Conclusions Patients with VD have a distinct clinical and neuropsychological profile that is mostly consistent across different methods for identifying the illness. These findings support the notion that MRI‐defined VD represents a unique and valid subtype of late‐life depression. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0885-6230</identifier><identifier>EISSN: 1099-1166</identifier><identifier>DOI: 10.1002/gps.3943</identifier><identifier>PMID: 23447432</identifier><identifier>CODEN: IJGPES</identifier><language>eng</language><publisher>Hove: Blackwell Publishing Ltd</publisher><subject>Age Factors ; Aged ; Aged, 80 and over ; Antidepressive Agents - therapeutic use ; Biological and medical sciences ; Cerebrovascular Disorders - diagnosis ; Cerebrovascular Disorders - physiopathology ; clinical characteristics ; Comparative analysis ; Depressive Disorder - diagnosis ; Depressive Disorder - drug therapy ; Depressive Disorder - physiopathology ; Double-Blind Method ; external validity ; Female ; General aspects ; Geriatric Assessment - methods ; Geriatric psychiatry ; Geriatric psychology ; Geriatrics ; Humans ; late-life depression ; Magnetic Resonance Imaging ; Male ; Medical sciences ; Mental depression ; Middle Aged ; Miscellaneous ; MRI ; Neuropsychological Tests ; Neuropsychology ; NMR ; Nortriptyline - therapeutic use ; Nuclear magnetic resonance ; Psychiatric Status Rating Scales ; Psychology. Psychoanalysis. Psychiatry ; Psychomotor Performance - physiology ; Psychopathology. Psychiatry ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Qualitative research ; Reproducibility of Results ; Sertraline - therapeutic use ; Sex Factors ; vascular depression</subject><ispartof>International journal of geriatric psychiatry, 2013-11, Vol.28 (11), p.1189-1196</ispartof><rights>Copyright © 2013 John Wiley &amp; Sons, Ltd.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright John Wiley and Sons, Limited Nov 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4173-25366c76f6c2a35e2bac3b79c96bcaae3ccce5f926c967ae3c834e6f615b3e033</citedby><cites>FETCH-LOGICAL-c4173-25366c76f6c2a35e2bac3b79c96bcaae3ccce5f926c967ae3c834e6f615b3e033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fgps.3943$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fgps.3943$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27774733$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23447432$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pimontel, Monique A.</creatorcontrib><creatorcontrib>Reinlieb, Michelle E.</creatorcontrib><creatorcontrib>Johnert, Lauren C.</creatorcontrib><creatorcontrib>Garcon, Ernst</creatorcontrib><creatorcontrib>Sneed, Joel R.</creatorcontrib><creatorcontrib>Roose, Steven P.</creatorcontrib><title>The external validity of MRI-defined vascular depression</title><title>International journal of geriatric psychiatry</title><addtitle>Int J Geriatr Psychiatry</addtitle><description>Objective Multiple diagnostic criteria have been used to define vascular depression (VD). As a result, there are discrepancies in the clinical characteristics that have been established for the illness. The aim of this study was twofold. First, we used empirically established diagnostic criteria to determine the clinical characteristics of magnetic resonance imaging (MRI)‐defined VD. Second, we assessed the agreement between a quantitative and qualitative method for identifying the illness. Method We examined the baseline clinical and neuropsychological profile of 38 patients from a larger, double‐blind, randomized, 12‐week clinical trial comparing nortriptyline with sertraline in depressed older adults. Ten patients met quantitative criteria for MRI‐defined VD based on the highest quartile of deep white matter hyperintensity (DWMH) volume. Fourteen patients met qualitative criteria for MRI‐defined VD based on a DWMH score of 2 or higher on the Fazekas' modified Coffey rating scale. Results Age, gender, cumulative illness rating scale‐geriatric (CIRS‐G) score, two measures of psychomotor retardation [the psychomotor retardation item of the Hamilton Rating Scale for Depression (HRSD) as well as performance on the Purdue Pegboard], and performance on the Stroop Color/Word test (a measure of the response inhibition component of executive functioning) were significantly different between those with VD and non‐VD. Conclusions Patients with VD have a distinct clinical and neuropsychological profile that is mostly consistent across different methods for identifying the illness. These findings support the notion that MRI‐defined VD represents a unique and valid subtype of late‐life depression. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cerebrovascular Disorders - diagnosis</subject><subject>Cerebrovascular Disorders - physiopathology</subject><subject>clinical characteristics</subject><subject>Comparative analysis</subject><subject>Depressive Disorder - diagnosis</subject><subject>Depressive Disorder - drug therapy</subject><subject>Depressive Disorder - physiopathology</subject><subject>Double-Blind Method</subject><subject>external validity</subject><subject>Female</subject><subject>General aspects</subject><subject>Geriatric Assessment - methods</subject><subject>Geriatric psychiatry</subject><subject>Geriatric psychology</subject><subject>Geriatrics</subject><subject>Humans</subject><subject>late-life depression</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mental depression</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>MRI</subject><subject>Neuropsychological Tests</subject><subject>Neuropsychology</subject><subject>NMR</subject><subject>Nortriptyline - therapeutic use</subject><subject>Nuclear magnetic resonance</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychomotor Performance - physiology</subject><subject>Psychopathology. Psychiatry</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Qualitative research</subject><subject>Reproducibility of Results</subject><subject>Sertraline - therapeutic use</subject><subject>Sex Factors</subject><subject>vascular depression</subject><issn>0885-6230</issn><issn>1099-1166</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10F1LHDEUBuBQKnW1BX9BGSiCN6NJTiaZuSx-rJZVi27xMmQyZ9rY2Zk12VH335upo0LBq5CTh_eQl5AdRvcZpfzg9zLsQyHgA5kwWhQpY1J-JBOa51kqOdBNshXCLaXxjeWfyCYHIZQAPiH5_A8m-LhC35omuTeNq9xqnXR1cn51llZYuxarOA-2b4xPKlx6DMF17WeyUZsm4Jfx3Ca_To7nh6fp7HJ6dvh9llrBFKQ8AymtkrW03ECGvDQWSlXYQpbWGARrLWZ1wWWcqOGeg8DIWVYCUoBtsvecu_TdXY9hpRcuWGwa02LXB82EAMhzRbNIv_1Hb7t--Nc_xYAxyvlboPVdCB5rvfRuYfxaM6qHNnVsUw9tRvp1DOzLBVav8KW-CHZHEAsyTe1Na114c0opoWAISp_dg2tw_e5CPf15PS4evQsrfHz1xv_VUoHK9M3FVM_E-Q86PZrrU3gCosqYYA</recordid><startdate>201311</startdate><enddate>201311</enddate><creator>Pimontel, Monique A.</creator><creator>Reinlieb, Michelle E.</creator><creator>Johnert, Lauren C.</creator><creator>Garcon, Ernst</creator><creator>Sneed, Joel R.</creator><creator>Roose, Steven P.</creator><general>Blackwell Publishing Ltd</general><general>Psychology Press</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201311</creationdate><title>The external validity of MRI-defined vascular depression</title><author>Pimontel, Monique A. ; Reinlieb, Michelle E. ; Johnert, Lauren C. ; Garcon, Ernst ; Sneed, Joel R. ; Roose, Steven P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4173-25366c76f6c2a35e2bac3b79c96bcaae3ccce5f926c967ae3c834e6f615b3e033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cerebrovascular Disorders - diagnosis</topic><topic>Cerebrovascular Disorders - physiopathology</topic><topic>clinical characteristics</topic><topic>Comparative analysis</topic><topic>Depressive Disorder - diagnosis</topic><topic>Depressive Disorder - drug therapy</topic><topic>Depressive Disorder - physiopathology</topic><topic>Double-Blind Method</topic><topic>external validity</topic><topic>Female</topic><topic>General aspects</topic><topic>Geriatric Assessment - methods</topic><topic>Geriatric psychiatry</topic><topic>Geriatric psychology</topic><topic>Geriatrics</topic><topic>Humans</topic><topic>late-life depression</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mental depression</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>MRI</topic><topic>Neuropsychological Tests</topic><topic>Neuropsychology</topic><topic>NMR</topic><topic>Nortriptyline - therapeutic use</topic><topic>Nuclear magnetic resonance</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychomotor Performance - physiology</topic><topic>Psychopathology. Psychiatry</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Qualitative research</topic><topic>Reproducibility of Results</topic><topic>Sertraline - therapeutic use</topic><topic>Sex Factors</topic><topic>vascular depression</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pimontel, Monique A.</creatorcontrib><creatorcontrib>Reinlieb, Michelle E.</creatorcontrib><creatorcontrib>Johnert, Lauren C.</creatorcontrib><creatorcontrib>Garcon, Ernst</creatorcontrib><creatorcontrib>Sneed, Joel R.</creatorcontrib><creatorcontrib>Roose, Steven P.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of geriatric psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pimontel, Monique A.</au><au>Reinlieb, Michelle E.</au><au>Johnert, Lauren C.</au><au>Garcon, Ernst</au><au>Sneed, Joel R.</au><au>Roose, Steven P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The external validity of MRI-defined vascular depression</atitle><jtitle>International journal of geriatric psychiatry</jtitle><addtitle>Int J Geriatr Psychiatry</addtitle><date>2013-11</date><risdate>2013</risdate><volume>28</volume><issue>11</issue><spage>1189</spage><epage>1196</epage><pages>1189-1196</pages><issn>0885-6230</issn><eissn>1099-1166</eissn><coden>IJGPES</coden><abstract>Objective Multiple diagnostic criteria have been used to define vascular depression (VD). As a result, there are discrepancies in the clinical characteristics that have been established for the illness. The aim of this study was twofold. First, we used empirically established diagnostic criteria to determine the clinical characteristics of magnetic resonance imaging (MRI)‐defined VD. Second, we assessed the agreement between a quantitative and qualitative method for identifying the illness. Method We examined the baseline clinical and neuropsychological profile of 38 patients from a larger, double‐blind, randomized, 12‐week clinical trial comparing nortriptyline with sertraline in depressed older adults. Ten patients met quantitative criteria for MRI‐defined VD based on the highest quartile of deep white matter hyperintensity (DWMH) volume. Fourteen patients met qualitative criteria for MRI‐defined VD based on a DWMH score of 2 or higher on the Fazekas' modified Coffey rating scale. Results Age, gender, cumulative illness rating scale‐geriatric (CIRS‐G) score, two measures of psychomotor retardation [the psychomotor retardation item of the Hamilton Rating Scale for Depression (HRSD) as well as performance on the Purdue Pegboard], and performance on the Stroop Color/Word test (a measure of the response inhibition component of executive functioning) were significantly different between those with VD and non‐VD. Conclusions Patients with VD have a distinct clinical and neuropsychological profile that is mostly consistent across different methods for identifying the illness. These findings support the notion that MRI‐defined VD represents a unique and valid subtype of late‐life depression. Copyright © 2013 John Wiley &amp; Sons, Ltd.</abstract><cop>Hove</cop><pub>Blackwell Publishing Ltd</pub><pmid>23447432</pmid><doi>10.1002/gps.3943</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0885-6230
ispartof International journal of geriatric psychiatry, 2013-11, Vol.28 (11), p.1189-1196
issn 0885-6230
1099-1166
language eng
recordid cdi_proquest_miscellaneous_1443388705
source MEDLINE; Access via Wiley Online Library
subjects Age Factors
Aged
Aged, 80 and over
Antidepressive Agents - therapeutic use
Biological and medical sciences
Cerebrovascular Disorders - diagnosis
Cerebrovascular Disorders - physiopathology
clinical characteristics
Comparative analysis
Depressive Disorder - diagnosis
Depressive Disorder - drug therapy
Depressive Disorder - physiopathology
Double-Blind Method
external validity
Female
General aspects
Geriatric Assessment - methods
Geriatric psychiatry
Geriatric psychology
Geriatrics
Humans
late-life depression
Magnetic Resonance Imaging
Male
Medical sciences
Mental depression
Middle Aged
Miscellaneous
MRI
Neuropsychological Tests
Neuropsychology
NMR
Nortriptyline - therapeutic use
Nuclear magnetic resonance
Psychiatric Status Rating Scales
Psychology. Psychoanalysis. Psychiatry
Psychomotor Performance - physiology
Psychopathology. Psychiatry
Public health. Hygiene
Public health. Hygiene-occupational medicine
Qualitative research
Reproducibility of Results
Sertraline - therapeutic use
Sex Factors
vascular depression
title The external validity of MRI-defined vascular depression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A07%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20external%20validity%20of%20MRI-defined%20vascular%20depression&rft.jtitle=International%20journal%20of%20geriatric%20psychiatry&rft.au=Pimontel,%20Monique%20A.&rft.date=2013-11&rft.volume=28&rft.issue=11&rft.spage=1189&rft.epage=1196&rft.pages=1189-1196&rft.issn=0885-6230&rft.eissn=1099-1166&rft.coden=IJGPES&rft_id=info:doi/10.1002/gps.3943&rft_dat=%3Cproquest_cross%3E3096114741%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1441311022&rft_id=info:pmid/23447432&rfr_iscdi=true